FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068831229> ?p ?o ?g. }

• W2068831229 endingPage "A84" @default.
• W2068831229 startingPage "A84" @default.
• W2068831229 abstract "The recent identification of a biallelic RAD51C (FANCO) mutation in a family with a Fanconi Anemia-like disorder led to its examination in a large hereditary breast and ovarian cancer case-control candidate study (Meindl, et al., 2010; Vaz, et al., 2010). Meindl et al. identified six independent pathogenic monoallelic mutations. Interestingly, these mutations were identified exclusively within 480 families with breast and ovarian cancer (frequency 1.3%) but not among any of the 620 families with breast cancer only. In most subsequent studies, the mutation frequency has been found to be lower than 1.3%, with only three additional truncating mutations being identified in five families among more than 729 ovarian cancer families (with or without breast cancer) (Akbari, et al., 2010; Pang, et al., 2011; Pelttari, et al., 2011; Romero, et al., 2011; Silvestri, et al., 2011; Wong, et al., 2011; Zheng, et al., 2010). Despite the presence of breast cancer in 10 of the 15 RAD51C mutation positive families reported to date, analysis of more than 1,373 breast cancer-only families by eight studies collectively has not identified any additional families with truncating RAD51C mutations. Therefore, while evidence of a causative role for RAD51C in breast and ovarian or ovarian only cancer families (HBOC) is convincing, albeit with low prevalence, its role in breast cancer only (HBC) families remains unclear.To provide more definitive data on the incidence of RAD51C mutations in hereditary breast and ovarian families, we utilised high resolution melt (HRM) analysis to screen for germline mutations in all coding exons of RAD51C in index cases from 1,388 non-BRCA1, non-BRCA2 high risk Australian HBC and HBOC families, and 427 controls. In addition, the contribution of RAD51C in unselected ovarian cancer was examined through the analysis of germline DNA from an unselected cohort of 267 ovarian cancer patients.Analysis of 1,053 HBC and 335 HBOC families, and 267 unselected ovarian cancer cases identified 12 novel heterozygous variants in RAD51C, three of which were protein truncating, six non-synonymous, one synonymous and two non-coding. Numerous dbSNPs and variants from previous studies were also identified. Two truncating mutations, c.72_73insTGCGG (p.V25CfsX3) and c.397C>T (p.Q133X), were identified amongst the 1,388 familial cases. Consistent with the previously reported deleterious mutations, both variants were identified in families with at least one report of ovarian cancer. A third truncating variant, c.230delG (p.G77VfsX24), was identified in a high grade serous tumour among the 267 unselected ovarian cancer cases. In silico analyses predict that four missense variants (including two novel variants) are likely to be pathogenic. Our data also provide support for the designation of the previously reported missense variants p.G264S, and possibly p.A126T, as moderate penetrance alleles." @default.
• W2068831229 created "2016-06-24" @default.
• W2068831229 creator A5006685339 @default.
• W2068831229 creator A5011692032 @default.
• W2068831229 creator A5019203355 @default.
• W2068831229 creator A5023347704 @default.
• W2068831229 creator A5037117618 @default.
• W2068831229 creator A5042368695 @default.
• W2068831229 creator A5042959020 @default.
• W2068831229 creator A5044795246 @default.
• W2068831229 creator A5046768806 @default.
• W2068831229 creator A5063597056 @default.
• W2068831229 creator A5081305748 @default.
• W2068831229 creator A5087168847 @default.
• W2068831229 date "2012-01-01" @default.
• W2068831229 modified "2023-10-10" @default.
• W2068831229 title "Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients" @default.
• W2068831229 cites W1254969687 @default.
• W2068831229 cites W1959448949 @default.
• W2068831229 cites W2002150942 @default.
• W2068831229 cites W2002419036 @default.
• W2068831229 cites W2013398180 @default.
• W2068831229 cites W2014395449 @default.
• W2068831229 cites W2017527770 @default.
• W2068831229 cites W2026954946 @default.
• W2068831229 cites W2067405457 @default.
• W2068831229 cites W2074720002 @default.
• W2068831229 cites W2101161126 @default.
• W2068831229 cites W2116506180 @default.
• W2068831229 cites W2126282065 @default.
• W2068831229 cites W2139760952 @default.
• W2068831229 cites W2140872369 @default.
• W2068831229 cites W2151206132 @default.
• W2068831229 cites W2167677949 @default.
• W2068831229 cites W2167844213 @default.
• W2068831229 doi "https://doi.org/10.1186/1897-4287-10-s2-a84" @default.
• W2068831229 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3326866" @default.
• W2068831229 hasPublicationYear "2012" @default.
• W2068831229 type Work @default.
• W2068831229 sameAs 2068831229 @default.
• W2068831229 citedByCount "0" @default.
• W2068831229 crossrefType "journal-article" @default.
• W2068831229 hasAuthorship W2068831229A5006685339 @default.
• W2068831229 hasAuthorship W2068831229A5011692032 @default.
• W2068831229 hasAuthorship W2068831229A5019203355 @default.
• W2068831229 hasAuthorship W2068831229A5023347704 @default.
• W2068831229 hasAuthorship W2068831229A5037117618 @default.
• W2068831229 hasAuthorship W2068831229A5042368695 @default.
• W2068831229 hasAuthorship W2068831229A5042959020 @default.
• W2068831229 hasAuthorship W2068831229A5044795246 @default.
• W2068831229 hasAuthorship W2068831229A5046768806 @default.
• W2068831229 hasAuthorship W2068831229A5063597056 @default.
• W2068831229 hasAuthorship W2068831229A5081305748 @default.
• W2068831229 hasAuthorship W2068831229A5087168847 @default.
• W2068831229 hasBestOaLocation W20688312291 @default.
• W2068831229 hasConcept C104317684 @default.
• W2068831229 hasConcept C109825262 @default.
• W2068831229 hasConcept C121608353 @default.
• W2068831229 hasConcept C126322002 @default.
• W2068831229 hasConcept C131872663 @default.
• W2068831229 hasConcept C13514818 @default.
• W2068831229 hasConcept C143998085 @default.
• W2068831229 hasConcept C2780427987 @default.
• W2068831229 hasConcept C29456083 @default.
• W2068831229 hasConcept C47042493 @default.
• W2068831229 hasConcept C501734568 @default.
• W2068831229 hasConcept C530470458 @default.
• W2068831229 hasConcept C54355233 @default.
• W2068831229 hasConcept C71924100 @default.
• W2068831229 hasConcept C86803240 @default.
• W2068831229 hasConceptScore W2068831229C104317684 @default.
• W2068831229 hasConceptScore W2068831229C109825262 @default.
• W2068831229 hasConceptScore W2068831229C121608353 @default.
• W2068831229 hasConceptScore W2068831229C126322002 @default.
• W2068831229 hasConceptScore W2068831229C131872663 @default.
• W2068831229 hasConceptScore W2068831229C13514818 @default.
• W2068831229 hasConceptScore W2068831229C143998085 @default.
• W2068831229 hasConceptScore W2068831229C2780427987 @default.
• W2068831229 hasConceptScore W2068831229C29456083 @default.
• W2068831229 hasConceptScore W2068831229C47042493 @default.
• W2068831229 hasConceptScore W2068831229C501734568 @default.
• W2068831229 hasConceptScore W2068831229C530470458 @default.
• W2068831229 hasConceptScore W2068831229C54355233 @default.
• W2068831229 hasConceptScore W2068831229C71924100 @default.
• W2068831229 hasConceptScore W2068831229C86803240 @default.
• W2068831229 hasIssue "Suppl 2" @default.
• W2068831229 hasLocation W20688312291 @default.
• W2068831229 hasLocation W20688312292 @default.
• W2068831229 hasLocation W20688312293 @default.
• W2068831229 hasLocation W20688312294 @default.
• W2068831229 hasOpenAccess W2068831229 @default.
• W2068831229 hasPrimaryLocation W20688312291 @default.
• W2068831229 hasRelatedWork W1932411143 @default.
• W2068831229 hasRelatedWork W1945350395 @default.
• W2068831229 hasRelatedWork W2023425329 @default.
• W2068831229 hasRelatedWork W2070739285 @default.
• W2068831229 hasRelatedWork W2239348802 @default.
• W2068831229 hasRelatedWork W2397920329 @default.

• next